Insiders Spero Therapeutics, Inc.

Equities

SPRO

US84833T1034

Market Closed - Nasdaq Other stock markets 21:00:00 07/05/2024 BST			5-day change	1st Jan Change
1.66 ^USD	0.00%		+16.90%	+12.93%

03-13	Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024
03-13	Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tamara Joseph Steps Down as Chief Legal Officer and Corporate Secretary of Spero Therapeutics, Inc, Effective as of March 6, 2024	02-09	CI
Spero Therapeutics Appoints Esther Rajavelu Chief Financial Officer	11-01	MT
Spero Therapeutics Appoints Esther Rajavelu as Chief Business Officer	11-01	CI
Spero Therapeutics Names Satyavrat Shukla Chief Executive	14/06/23	MT
Spero Therapeutics, Inc. Announces Chief Executive Officer Changes	14/06/23	CI
Spero Therapeutics, Inc. Announces Executives Changes, Effective August 1, 2023	14/06/23	CI
Spero Therapeutics, Inc. Appoints Timothy Keutzer as Chief Operating Officer, Effective as of February 1, 2023	01/02/23	CI
Spero Therapeutics Announces Appointment of Kamal Hamed as Chief Medical Officer	15/09/22	CI
Spero Therapeutics, Inc. Announces Executive Changes	03/05/22	CI
Insider Buy: Spero Therapeutics	03/01/22	MT
Spero Therapeutics, Inc. Appoints Kathleen Tregoning to Its Board of Directors	12/10/21	CI
Insider Trends: Insider Prolongs Selling Trend at Spero Therapeutics	04/02/21	MT
Insider Trends: Selling By Insiders Lingers at Spero Therapeutics	18/12/20	MT
Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer, Effective as of January 4, 2021	17/12/20	CI
Spero Therapeutics, Inc. Appoints Tamara Joseph as Chief Legal Officer	02/12/20	CI
Insider Trends: Spero Therapeutics Insider Continues 90-Day Selling Trend	11/11/20	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Spero Therapeutics	07/11/20	MT
Spero Therapeutics, Inc. Appoints Scott Jackson to the Audit Committee of the Board, Effective May 15, 2020	11/05/20	CI
Spero Announces Appointment of Scott Jackson to Its Board of Directors	16/04/20	CI
Spero Therapeutics, Inc. Announces Step Down of David P. Southwell from its Board of Directors	18/04/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Spero Therapeutics, Inc.

Equities

SPRO

US84833T1034

Insiders

Filters